Famitinib enhances the antitumor effect of radioimmunotherapy in murine lung cancer.
Meng YuanYirui ZhaiYu MenMaoyuan ZhaoXin SunZeliang MaXu YangShuang SunYongxing BaoYunsong LiuZhouguang HuiPublished in: Thoracic cancer (2022)
Famitinib can synergize with radioimmunotherapy by regulating the tumor immune microenvironment in murine lung cancer.
Keyphrases